Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Cefazolin
Drug ID BADD_D00382
Description A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.
Indications and Usage Mainly used to treat bacterial infections of the skin. It can also be used to treat moderately severe bacterial infections involving the lung, bone, joint, stomach, blood, heart valve, and urinary tract. It is clinically effective against infections caused by staphylococci and streptococci species of Gram positive bacteria. May be used for surgical prophylaxis; if required metronidazole may be added to cover B. fragilis.
Marketing Status approved
ATC Code J01DB04
DrugBank ID DB01327
KEGG ID D02299
MeSH ID D002437
PubChem ID 33255
TTD Drug ID D09KDN
NDC Product Code 0409-2585; 0143-9923; 0781-3451; 0404-9833; 72572-055; 60505-6231; 0781-3450; 60505-6142; 60505-6143; 71872-7027; 44567-707; 44567-840; 52584-924; 71205-679; 72572-056; 60505-6243; 17337-0300; 0143-9924; 44567-120; 52584-087; 60505-6244; 67184-0560; 67184-1001; 0404-9835; 44567-706; 52584-923; 70518-3047; 0143-9262; 0404-9834; 71872-7141; 0781-3452; 0143-9139; 0143-9140; 0143-9261; 0143-9665; 0143-9983; 44567-708
UNII IHS69L0Y4T
Synonyms Cefazolin | Cephazolin | Cefamedin | Cefamezine | Cephamezine | Gramaxin | Kefzol | Totacef | Ancef | Cefazolin Sodium | Sodium, Cefazolin | Sodium Cephazolin | Cephazolin, Sodium | Cephazolin Sodium | Sodium, Cephazolin
Chemical Information
Molecular Formula C14H14N8O4S3
CAS Registry Number 25953-19-9
SMILES CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Localised oedema14.05.06.009; 08.01.07.011; 02.05.04.0060.000049%
Shock haemorrhagic24.06.02.014; 14.05.05.0030.000122%Not Available
Type IV hypersensitivity reaction10.01.03.0220.000107%Not Available
Haemorrhage24.07.01.0020.000122%Not Available
Vulvovaginal pruritus23.03.12.009; 21.08.02.004--Not Available
Paraesthesia oral07.05.05.035; 17.02.06.0080.000049%Not Available
Toxic skin eruption12.03.01.073; 23.03.05.003; 10.01.01.0080.000073%Not Available
Drug resistance08.06.01.0050.000049%Not Available
Induration08.01.03.020--Not Available
Biliary tract disorder09.02.03.0010.000049%Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Blood disorder01.05.01.004--Not Available
Renal impairment20.01.03.0100.000131%Not Available
Effusion08.01.03.0520.000073%Not Available
Bone marrow failure01.03.03.0050.000073%
Treatment failure08.06.01.0170.000049%Not Available
Liver injury09.01.07.022; 12.01.17.012--Not Available
Post procedural infection12.02.05.010; 11.01.08.019--Not Available
Low birth weight baby18.04.02.0030.000049%Not Available
Anal pruritus07.03.03.002--Not Available
Anorectal discomfort07.03.03.003--Not Available
Kounis syndrome24.04.04.020; 10.01.03.037; 02.02.02.0200.000243%Not Available
Acute kidney injury20.01.03.0160.000365%
Noninfectious peritonitis07.07.01.0050.000049%Not Available
Drug-induced liver injury12.03.01.044; 09.01.07.0230.000812%Not Available
Drug reaction with eosinophilia and systemic symptoms12.03.01.064; 23.03.05.005; 10.01.01.0210.000097%Not Available
Candida infection11.03.03.021--
Antiphospholipid syndrome24.01.01.029; 18.02.04.002; 10.04.01.009; 01.01.02.0160.000049%Not Available
Hemiplegic migraine24.03.05.012; 17.14.02.004--Not Available
Necrotising oesophagitis07.04.05.0060.000049%Not Available
The 7th Page    First    Pre   7 8    Next   Last    Total 8 Pages